Cargando…
Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features
Background: This study aimed to predict pathologic complete response (pCR) in neoadjuvant chemotherapy for ER+HER2- locally advanced breast cancer (LABC), a subtype with limited treatment response. Methods: We included 265 ER+HER2- LABC patients (2010–2020) with pre-treatment MRI, neoadjuvant chemot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572844/ https://www.ncbi.nlm.nih.gov/pubmed/37835774 http://dx.doi.org/10.3390/diagnostics13193031 |
_version_ | 1785120327546699776 |
---|---|
author | Park, Jiwoo Kim, Min Jung Yoon, Jong-Hyun Han, Kyunghwa Kim, Eun-Kyung Sohn, Joo Hyuk Lee, Young Han Yoo, Yangmo |
author_facet | Park, Jiwoo Kim, Min Jung Yoon, Jong-Hyun Han, Kyunghwa Kim, Eun-Kyung Sohn, Joo Hyuk Lee, Young Han Yoo, Yangmo |
author_sort | Park, Jiwoo |
collection | PubMed |
description | Background: This study aimed to predict pathologic complete response (pCR) in neoadjuvant chemotherapy for ER+HER2- locally advanced breast cancer (LABC), a subtype with limited treatment response. Methods: We included 265 ER+HER2- LABC patients (2010–2020) with pre-treatment MRI, neoadjuvant chemotherapy, and confirmed pathology. Using data from January 2016, we divided them into training and validation cohorts. Volumes of interest (VOI) for the tumoral and peritumoral regions were segmented on preoperative MRI from three sequences: T1-weighted early and delayed contrast-enhanced sequences and T2-weighted fat-suppressed sequence (T2FS). We constructed seven machine learning models using tumoral, peritumoral, and combined texture features within and across the sequences, and evaluated their pCR prediction performance using AUC values. Results: The best single sequence model was SVM using a 1 mm tumor-to-peritumor VOI in the early contrast-enhanced phase (AUC = 0.9447). Among the combinations, the top-performing model was K-Nearest Neighbor, using 1 mm tumor-to-peritumor VOI in the early contrast-enhanced phase and 3 mm peritumoral VOI in T2FS (AUC = 0.9631). Conclusions: We suggest that a combined machine learning model that integrates tumoral and peritumoral radiomic features across different MRI sequences can provide a more accurate pretreatment pCR prediction for neoadjuvant chemotherapy in ER+HER2- LABC. |
format | Online Article Text |
id | pubmed-10572844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105728442023-10-14 Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features Park, Jiwoo Kim, Min Jung Yoon, Jong-Hyun Han, Kyunghwa Kim, Eun-Kyung Sohn, Joo Hyuk Lee, Young Han Yoo, Yangmo Diagnostics (Basel) Article Background: This study aimed to predict pathologic complete response (pCR) in neoadjuvant chemotherapy for ER+HER2- locally advanced breast cancer (LABC), a subtype with limited treatment response. Methods: We included 265 ER+HER2- LABC patients (2010–2020) with pre-treatment MRI, neoadjuvant chemotherapy, and confirmed pathology. Using data from January 2016, we divided them into training and validation cohorts. Volumes of interest (VOI) for the tumoral and peritumoral regions were segmented on preoperative MRI from three sequences: T1-weighted early and delayed contrast-enhanced sequences and T2-weighted fat-suppressed sequence (T2FS). We constructed seven machine learning models using tumoral, peritumoral, and combined texture features within and across the sequences, and evaluated their pCR prediction performance using AUC values. Results: The best single sequence model was SVM using a 1 mm tumor-to-peritumor VOI in the early contrast-enhanced phase (AUC = 0.9447). Among the combinations, the top-performing model was K-Nearest Neighbor, using 1 mm tumor-to-peritumor VOI in the early contrast-enhanced phase and 3 mm peritumoral VOI in T2FS (AUC = 0.9631). Conclusions: We suggest that a combined machine learning model that integrates tumoral and peritumoral radiomic features across different MRI sequences can provide a more accurate pretreatment pCR prediction for neoadjuvant chemotherapy in ER+HER2- LABC. MDPI 2023-09-23 /pmc/articles/PMC10572844/ /pubmed/37835774 http://dx.doi.org/10.3390/diagnostics13193031 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Jiwoo Kim, Min Jung Yoon, Jong-Hyun Han, Kyunghwa Kim, Eun-Kyung Sohn, Joo Hyuk Lee, Young Han Yoo, Yangmo Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features |
title | Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features |
title_full | Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features |
title_fullStr | Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features |
title_full_unstemmed | Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features |
title_short | Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features |
title_sort | machine learning predicts pathologic complete response to neoadjuvant chemotherapy for er+her2- breast cancer: integrating tumoral and peritumoral mri radiomic features |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572844/ https://www.ncbi.nlm.nih.gov/pubmed/37835774 http://dx.doi.org/10.3390/diagnostics13193031 |
work_keys_str_mv | AT parkjiwoo machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures AT kimminjung machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures AT yoonjonghyun machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures AT hankyunghwa machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures AT kimeunkyung machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures AT sohnjoohyuk machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures AT leeyounghan machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures AT yooyangmo machinelearningpredictspathologiccompleteresponsetoneoadjuvantchemotherapyforerher2breastcancerintegratingtumoralandperitumoralmriradiomicfeatures |